Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Efizonerimod |
Trade Name | |
Synonyms | MEDI-6383|MEDI 6383|MEDI6383 |
Drug Descriptions |
Efizonerimod (MEDI6383) is a fusion protein that binds to TNFRSF4 (OX40, CD134) and mimics the binding of the ligand, TNFSF4 (OX40L, CD252), to stimulate proliferation of T-cells and enhance an anti-tumor response (Journal of Clinical Oncology 33, no. 15_suppl (May 20 2015) 3056-3056, PMID: 29545330). |
DrugClasses | |
CAS Registry Number | 1635395-27-5 |
NCIT ID | C118282 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Efizonerimod | Efizonerimod | 0 | 1 |